Por: RTTNews Health December 09, 2022
Although biotech stocks are highly speculative, they offer investors tremendous opportunities. As 2022 draws to a close, we take a look at some of the healthcare stocks we profiled that delivered triple-digit gains. HeadlinePublished DatePublished PriceMaximum Price Since PublicationLast Closing PriceMax Gain %Feb. 1$0.70$4.68$2.24569%Aug. 2$1.33$7.35$1.45453%Jun. 16$1.24$6.74$5.85444%Feb. 28$1.76$8.18$1.51365%May. 16$4.02$18.07$11.23350%Feb.... + full article
Forbes USA Business December 17, 2022
Losses, losses everywhereJohn Tobey (Financial Visualizations - FinViz.com) Last month, I described why a stock market shakeout was likely. Such episodes are meant to shake out remaining weak investors from previously popular stocks, resetting values and creating strong... + más
Train derails in Piscataquis County due to track washout | Portland Press Herald
Morgan Stanley CEO James Gorman says there's about to be a washout of fintech valuations and a wave of consolidation. Here's how the bank is thinking about potential deals. | Business Insider
Forbes USA Business December 06, 2022
syringe sticking out of raw chickengetty Even combining cell-cultured meat with plant-based ingredients will still prove impossible to compete with the real thing in the marketplace. Recently, the U.S. Food and Drug Administration its “no questions” letter in response to... + más
Small amounts of dairy may protect against Type 2 diabetes: Study | Newsweek
Beyond Meat COO reportedly attempts to consume human nose | The Verge
The Boston Globe USA Business November 15, 2022
A Boston biotech founded by researchers at the Broad Institute of MIT and Harvard has landed $157 million for its big plans to develop pills for cancer, immune conditions, neurological diseases, and a rare metabolic disorder.Jnana Therapeutics announced Tuesday that it raised a... + más
Ganni Ventures Into Beauty For The First Time With Sustainable Glitter Launch | Forbes
LabCentral opens its biggest site yet in the heart of Kendall Square | The Boston Globe
The Boston Globe USA Business November 11, 2022
Barely a year after he was named head of the Massachusetts Biotechnology Council, former state Senator Joseph Boncore has been ousted and will be replaced with the trade group’s second-highest executive, according to two members of the nonprofit organization’s board of... + más
Is Boston reaching ‘peak lab’? | The Boston Globe
Pokemon Scarlet and Violet November 2022 trade codes | Newsweek
Forbes USA Business November 05, 2022
Of every hundred entry-level men promoted to manager positions, only eighty-seven women receive promotions. Because of this, significantly more men than women are involved in leadership, and the inequality does not seem to be reducible, according to the latest Women in the... + más
Breaching the U.S. debt ceiling would be a 'disaster' for Americans, expert says, as possible showdown looms if Republicans win midterms | MarketWatch
Sanders opposes eliminating the debt ceiling, argues GOP has no economic plan beyond criticism | ABC News
The Boston Globe USA Business October 20, 2022
PROVIDENCE — In the nearly four decades Neil Steinberg has been working in downtown Providence, he’s heard hype of a “spillover” effect from Boston to Providence when it comes to the life sciences industry.He watched as Cambridge, Massachusetts; Manchester, New... + más
Nobel Prize in economic sciences goes to former U.S. Federal Reserve chairman and American economists | New York Daily News
Tech insiders have a lot to say about the local startup scene. Most of it is good. | The Boston Globe
The Boston Globe USA Tech October 13, 2022
LabCentral, a biotech incubator that has fostered hundreds of startups at its shared lab spaces in Cambridge, is tripling its footprint with a new 100,000-square-foot lab, office, and manufacturing facility. The site, which is opening at a time when lab leases are commanding... + más
In a work-from-anywhere world, how will Kendall Square adapt for the future? | The Boston Globe
Broad scales up as Biogen scales back in Kendall Square | The Boston Globe
About iurex | Privacy Policy | Disclaimer |